Pharmacology L4: Parkinson's Disease Flashcards

1
Q

What are 5 etiology for Parkinson’s Disease?

A
  1. Age: the most important risk factor
  2. Family history for PD
  3. Male gender
  4. Environment? Exposure to manganese and iron, pesticide/herbicides, well water, rural farming(?)
  5. Trauma, emotional stress, repetitive head injury(?)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What are the 4 symptoms of Parkinson’s Disease?

A

Remember: “TRAP”

  • Tremor at rest,
  • Rigidity (Very challenging = no fluidity of movement) of limbs,
  • Akinesia,
  • Postural problems (leading to loss of balance)
    • Forward tilt of trunk region, shuffling gait, rigidity of extremities, short steps

Relative new disease (100yrs)

Exposed to poisons on a regulate basis (PD developed/correlation from industrial revolution) = theory

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Most common form is idiopathic “____” (shaking palsy).

A

paralysis agitans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Without treatment, PD progresses over 5-10 years to a _____ state with patients unable to care for themselves.

A

rigid akinetic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Death may result from complications of immobility, including______ or ____.

A

aspiration pneumonia; pulmonary embolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

_____ has radically altered and postponed this outcome, but overall mortality remains higher than in the general population.

A

Pharmacology

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is the cure/treatment for PD?

A

While there are treatments to manage symptoms, there is NO cure for the degeneration dopaminergic neurons (substantia nigra pars compacta)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the cause of PD?

A

due to the selective loss of dopaminergic neurons in the substantia nigra of the brain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is the substantia nigra?

A

the major origin of dopaminergic innervation of the striatum, a main function of which is regulation of posture and muscle tone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What does post-mortem brains of PD patients have?

A

only 10% of normal dopamine levels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What can also be found in dopaminergic neurons in PD patients?

A

Lewy bodies (a-synuclein) may also found in dopaminergic neurons – synuclein is involved in vesicular recycling, so loss may prevent DA from being packaged effectively.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

About 60-80% loss of dopaminergic neurons occurs before ______ symptoms are seen.

A

motor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the problem with proteins behaving badly to nervous systems?

A

Improperly deposited = disruption of movement (between and within neurons) = trigger for neuronal death Plaque

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What does a substantia nigra in a PD patient look like?

A

Darkly tinted cells (dopaminergic neurons) are reducing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What does DA look like in normal and PD patients?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Effective treatment may include increasing ____ or decreasing of the effects of ____ within the brain, so that initial balance is somewhat restored.

A

DA; ACh

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What is the dopamine in CNS synapse?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What could ideally be done to increase dopamine concentrations in the synapses?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

What is drugs that can be converted into dopamine?

A
  • Levodopa (L-Dopa), a precursor of dopamine, is the major initial drug used in treatment.
  • It can cross the blood-brain barrier, is presumed to be taken up by dopaminergic neurons which convert it to dopamine centrally.
  • Dopamine itself cannot cross the BBB.
  • This would increase the concentration of dopamine available for use in the CNS.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What are anti-parkinson drugs?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Why should Levodopa (L-dopa) be taken with Carbidopa?

A

Carbidopa protects the conversion of L-dopa to dopamine (esp. in periphery) so that it can be converted in CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What does COMT work in PD?

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

What are drugs that inhibit the metabolism of dopamine?

A
  • Rasagiline, a selective MAO-B inhibitor, may slow the normal degradation of dopamine in the brain and preserve it for recycling into vesicles.
  • Use of sustained release preparations of L-DOPA or addition of COMT inhibitors, such as entacapone, may counteract fluctuations of L-DOPA.
  • Due to gliosis, more MAO-B is found in the brains of patients with PD; MAO-B activity levels are doubled in the substantia nigra in PD and correlate with the percentage of dopaminergic cell loss.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

What is the theory of dopamine receptor agonists?

A

Theory: these compounds would act directly on postsynaptic dopamine receptors even if presynaptic dopamine-releasing neurons have degenerated.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

In PD, there is greater loss of ____ (D1/D2) receptors relative to ____(D1/D2) subtype; recall that DA is largely modulatory in its effects in the substantia nigra.

A

D2; D1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

What is Bromocriptine?

A

a strong agonist at D2 receptors and a partial agonist at D1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

What are newer drugs such as pramipexole and ropinirole?

A

agonists at D2 receptor with little to no affinity for D1 or alpha adrenergic receptors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

What is Amantadine initially developed as?

A

Originally developed as a synthetic antiviral agent, and it was randomly found to be effective in Parkinson’s disease.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

How is amantadine used?

A

Seems to increase dopamine release from surviving nigral neurons, mechanism is unclear.

30
Q

What is the effectiveness of Amantadine as treatment?

A

levodopa-induced dyskinesias.

31
Q

What is the function of Amantadine?

A

Recently, amantadine has been shown to be an antagonist at the NMDA glutamate receptor, and may play a role in neurotransmitter balance as well as reduction of excitotoxicity.

32
Q

What is the benefit of Amatadine vs L-dopa, while it is less effective?

A

Amantadine is less effective than L-Dopa, but also has fewer side-effects. Tolerance to its benefits seems to develop after 6-8 months of use.

33
Q

Which one is more effective? Amatadine vs L-dopa

A

L-dopa

34
Q

Which one has less side effects? Amatadine vs L-dopa

A

Amantadine

35
Q

What can be done between Amatdine and L-dopa?

A

Can be used in conjunction

36
Q

How can you reduce activity of acetylcholine as treatment for PD?

A
  • Muscarinic blockers, such as atropine-like benztropine, has been used for more than 100 years, and were the first pharmacological treatments used in PD.
  • They are generally less effective than levodopa, and their host of side effects (blurred vision, dry mouth, constipation, urinary retention) make them less used.
  • However, they may be useful as supplementary agents, combined with L-Dopa.
37
Q

What is the 3 surgical treatments for PD?

A
  1. Brain stimulation technology may benefit patients with advanced, levodopa-resistant Parkinson’s disease.
  2. The subthalamic nucleus (STN)
  3. the globus pallidus interna (GPi)
    • are targeted to suppress some of the disabling symptoms of Parkinson’s disease.
38
Q

What is the purpose of surgery for PD?

A

Not to treat PD, rather the adverse effects or having the L-dopa medication over time (side effects)

39
Q

In DBS, 20% patients undergo surgery with ____-_____% success rate

A

65-85

40
Q

How does DBS work for PD? List 3 characteristics

A
  1. By targeting the brain’s message relay centers, subthalamic nucleus (STN) or internal globus pallidus (Gpi), DBS works by stimulating the area that influences motor control.
  2. The system delivers electrical pulses that affect brain cell activity, blocking selected brain areas to alleviate movement problems.
  3. Most cases require bilateral implantations.
41
Q

The most important predictor of success of DBS for PD is a history of initial excellent response to ______.

A

L-dopa

42
Q

_____ and _____ are key aspects of Parkinson’s disease, especially in its younger sufferers. Why?

A

Depression; anxiety

Very confronting condition and the treatment (eg. dosage)

43
Q

Queensland is a “hot spot” for ____. Approximately 100,000 Australians suffer from PD

A

PD

44
Q

We have no current treatment to address the loss of _____ neurons.

A

dopaminergic

45
Q

_____ attempts to address the DA deficiency via a number of avenues, but resolution is far from perfect.

A

Pharmacology

46
Q

____ mechanism is not completely understood with a 25% failure rate.

A

DBS

47
Q

What is Huntington’s Chorea/Huntington’s Disease (HD)?

A

HD is also a neurodegenerative disease in the basal ganglia

48
Q

How does the body get affected by Huntington’s Chorea/Huntington’s Disease (HD)?

A
  • Instead of slowing movements down, the hallmark symptoms are uncontrolled writhing of the muscles in the face, trunk and neck.
  • While the body’s movement is distorted continuously, there is also progressive dementia.
49
Q

How is Huntington’s Chorea/Huntington’s Disease (HD) get transmitted?

A

autosomal dominant

50
Q

Each child of a HD-afflicted parent has _____% chance of inheriting the disease.

A

50

51
Q

What is the onset for Huntington’s Chorea/Huntington’s Disease (HD)?

A
  • Disease onset is usually in the 30s and 40s, but more than 60 repeats of CAG are associated with HD before age 20.
  • But by 40s, many people have already had children and passed the disease on.
52
Q

20 years ago or so, what was the possible treatment to ensure HD is not passed on? What is done now?

A

voluntarily sterilization

  • Make sure genes aren’t passed on
  • Consider adoption

We now have a genetic test to determine if patients are carriers, and children can be conceived in vitro and break the cycle.

53
Q

Is it good to be tested for HD?

A
  • Can give life choices but carries psychological baggage = you know what you will face in the future with the disease
  • Much few incidences now
54
Q

What is the culprit in HD?

A

huntingtin protein

55
Q

What is the huntingtin protein?

A
  • Found in cells throughout the body, but has most damage within basal ganglia of the brain.
  • “CAG” trinucleotide repeats add glutamine residues to the protein.
  • Normally, the CAG sequence repeats 11-30 times.
  • People with HD may have repeats of 36- 125 times.
  • Excess glutamines cause huntingtin protein to mis-fold, and not function for cellular transport as normal.
56
Q

What causes the huntingtin protein to misfold?

A
  • Excess glutamines cause huntingtin protein to mis-fold, and not function for cellular transport as normal.
  • More repeats = more glutamines = more severe/earlier onset HD
57
Q

What is happening to the neurons in HD?

A
  • In post-mortem brains, there is a 75% reduction in activity of glutamic acid decarboxylase, an enzyme responsible for synthesis of GABA.
  • It is thought that with GABA concentrations declining in the brain, dopaminergic circuits are allowed to operate without the usual “brake”.
58
Q

How is the “brake” lost? Death of GABAergic neurons.

A

Top: DAergic neurons from substantia nigra usually inhibit GABAergic output from the striatum, while cholinergic neurons are excitatory.

Bottom: In HD, GABAergic neurons degenerate. Inhibitory regulation is lost, with net excitation as the result, leading to uncontrolled motor activity.

59
Q

How can we treat loss of GABAergic neurons, and overactivity of dopaminergic neurons?

A
  • General strategy is to reduce neuronal activity in key brain regions, or to antagonise dopamine activity.
  • Chorea can be suppressed by using drugs which deplete dopamine and other neurotransmitters; such as tetrabenazine.
  • Antagonists to dopamine receptors may also be used in patients, such as haloperidol, which improves motor function and psychosis associated with HD.
60
Q

What is putative mechanisms of action of TBZ?

A
61
Q

What are the 2 alternative treatments of HD?

A
  1. Experimental transplant of fetal brain tissue has been attempted in a few patients; early results show promise, but more research needs to be done.
  2. Deep brain stimulation has been tried in HD patients, targetting the globus pallidus.
    1. It is thought that DBS silences brain cells in their vicinity, disrupting the activity patterns causing chorea.
62
Q

Parkinson’s Disease strategies generally increase the contribution of dopamine to voluntary muscle movement. (T/F) EXAM QUESTION

A

False

63
Q

Why is PD pharmacological treatment less effective over time?

EXAM QUESTION

A

q

64
Q

What are the key physical features of PD?

EXAM QUESTION

A

TRAP Tremour Rigidity of limbs Akinesia Posture problems

65
Q

Why is L-DOPA combined with carbidopa in PD?

EXAM QUESTION

A

Able to slow down the conversion of L-dopa into DA in the periphery so there is more that converts in the brain

66
Q

What key neurotransmitters are involved in HD?

EXAM QUESTION

A

a

67
Q

What key neurotransmitters are involved in HD?

EXAM QUESTION

A

Autosomal dominant

68
Q

Why would be it advisable for patients to regularly be seen by their health professionals if they suffer from PD or HD?

EXAM QUESTION

A

a

69
Q

Compare and contrast PD and HD in terms of symptoms, brain areas involved, and treatment.

EXAM QUESTION

A

a

70
Q

Explain the mechanism of action of one drug used to treat PD and HD.

EXAM QUESTION

A

a